Biomarker for therapy of recurrent cancer after radiation treatment

摘要

The present invention provides information for identifying a patient suffering from radiation-resistant recurrent cancer that is suitable for the administration of a target drug for metabolism, including the step of confirming the mutation of the amino acid sequence or the gene sequence of p53 protein in cancer cells surviving radiation irradiation separated from the patient The method comprising: